Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Tryp Therapeutics logo — Tryp is leading the next wave of psychedelic drug developmen...

Tryp Therapeutics

Tryp is leading the next wave of psychedelic drug development.

Founded 2019 Australia Melbourne, Australia 9 employees Post Ipo Equity Total: $20.12M Biotechnology

General Information

Company Name Tryp Therapeutics
Founded Year 2019
Location Australia Melbourne, Australia +1
Employees 9
Industries Biotechnology
Funding Stage Post Ipo Equity
Social

Get notified when Tryp Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Tryp Therapeutics

Tryp Therapeutics is a pioneering biotechnology startup with the slogan "Tryp is leading the next wave of psychedelic drug development." The company is focused on developing novel formulations for the administration of psilocin in combination with psychotherapy to address diseases with unmet medical needs. Their lead program, TRP-8803, a proprietary formulation of IV-infused psilocin, aims to alleviate the limitations of oral psilocybin. Tryp has ongoing Phase 2a clinical trials for the treatment of Binge Eating Disorder at the University of Florida and upcoming trials for the treatment of fibromyalgia at the University of Michigan, both exhibiting potential in utilizing TRP-8802. The company, founded in 2019 and based in the United States, received a $6.50M Post-IPO Equity investment on 01 May 2024. The potential of TRP-8803 to enhance efficacy, safety, and patient experience indicates promising future prospects in the biotechnology industry.

Taxonomy: psychedelic drug development, clinical-stage, psilocin, psychotherapy, neuropsychiatric disorders, clinical trial, Binge Eating Disorder, fibromyalgia, IV-infused psilocin, synthetic psilocybin, drug formulation, therapeutic dosing, psychedelic experience, patient experience

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 01 May 2024
Post-IPO Debt •••••• 1 •••• •••• 02 Nov 2023
Post-IPO Debt •••••• - 12 Apr 2023
Post-IPO Equity •••••• - 04 Feb 2022
Post-IPO Equity •••••• 1 •••• •••• 05 Feb 2021

Tryp Therapeutics Alternatives & Competitors

Tryp Therapeutics vs
Clairvoyant Therapeutics
Clairvoyant Therapeutics Canada

Trailblazing a path to global mental health through psilocybin therapy

Seed
8 employees
Biotechnology, Health and Wellness
Tryp Therapeutics vs
MindBio Therapeutics
MindBio Therapeutics Australia

Advancing mental health treatments. Multiple Phase 2B clinical trials underway. Publicly listed on C...

4 employees
Pharmaceutical
Tryp Therapeutics vs
Kinarus Therapeutics
Kinarus Therapeutics Switzerland

Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respiratory and ocu...

Post Ipo Equity
5 employees
Biopharma, Biotechnology

FAQ About Tryp Therapeutics

Tryp is leading the next wave of psychedelic drug development.
Tryp Therapeutics was founded in 2019.
Tryp Therapeutics is headquartered in Melbourne, Australia.
Tryp Therapeutics operates in the following industries: Biotechnology.
Tryp Therapeutics has approximately 9 employees.
Tryp Therapeutics has completed 5 funding rounds, raising a total of $20.12M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Tryp Therapeutics include Clairvoyant Therapeutics, MindBio Therapeutics, Kinarus Therapeutics, Molecular Templates, Enterome. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tryp Therapeutics and Clairvoyant Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Tryp Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy